Phytochemical modulation of the Akt/mTOR pathway and its potential use in cutaneous disease

Michael S. Leo, Raja K Sivamani

Research output: Contribution to journalArticle

14 Scopus citations

Abstract

The mechanistic target of rapamycin (mTOR) is involved in the regulation of cellular growth, proliferation, lipid synthesis, and protein translation. The mTOR pathway involves two complexes: the mechanistic target of rapamycin complex 1 (mTORC1) and the mechanistic target of rapamycin complex 2 (mTORC2). Both mTOR complexes have been implicated in the development and progression of various skin diseases including melanoma, psoriasis, and acne vulgaris. Here, we review the role of both mTORC1 and mTORC2 as well as their upstream modulators, phosphoinositide 3-kinase (PI3K) and protein kinase B (Akt), and their downstream targets in various dermatologic diseases. Phytochemicals, plant-derived naturally occurring compounds, have been shown to regulate the mTOR pathway and may serve as novel therapeutic agents in dermatological disease. Here, we review phytochemicals in the context of the mTOR pathway and their potential use in cutaneous disease.

Original languageEnglish (US)
Pages (from-to)861-871
Number of pages11
JournalArchives of Dermatological Research
Volume306
Issue number10
DOIs
StatePublished - Dec 1 2014

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Phytochemical modulation of the Akt/mTOR pathway and its potential use in cutaneous disease'. Together they form a unique fingerprint.

  • Cite this